Literature DB >> 9697205

Protein disorder and the evolution of molecular recognition: theory, predictions and observations.

A K Dunker1, E Garner, S Guilliot, P Romero, K Albrecht, J Hart, Z Obradovic, C Kissinger, J E Villafranca.   

Abstract

Observations going back more than 20 years show that regions in proteins with disordered backbones can play roles in their binding to other molecules; typically, the disordered regions become ordered upon complex formation. Thought-experiments with Schulz Diagrams, which are defined herein, suggest that disorder-to-order transitions are required for natural selection to operate separately on affinity and specificity. Separation of affinity and specificity may be essential for fine-tuning the molecular interaction networks that comprise the living state. For low affinity, high specificity interactions, our analysis suggests that natural selection would parse the amino acids conferring flexibility in the unbound state from those conferring specificity in the bound state. For high affinity, low specificity or for high affinity, multiple specificity interactions, our analysis suggests that the disorder-to-order transitions enable alternative packing interactions between side chains to accommodate the different binding targets. Disorder-to-order transitions upon binding also have significant kinetic implications as well, by having complex effects on both on- and off-rates. Current data are insufficient to decide on these proposals, but sequence and structure analysis on two examples support further investigations of the role of disorder-to-order transitions upon binding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697205

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  152 in total

Review 1.  Natively unfolded proteins: a point where biology waits for physics.

Authors:  Vladimir N Uversky
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

2.  Improved amino acid flexibility parameters.

Authors:  David K Smith; Predrag Radivojac; Zoran Obradovic; A Keith Dunker; Guang Zhu
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

3.  Proteomics of Mycoplasma genitalium: identification and characterization of unannotated and atypical proteins in a small model genome.

Authors:  S Balasubramanian; T Schneider; M Gerstein; L Regan
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

4.  Rapid refinement of crystallographic protein construct definition employing enhanced hydrogen/deuterium exchange MS.

Authors:  Dennis Pantazatos; Jack S Kim; Heath E Klock; Raymond C Stevens; Ian A Wilson; Scott A Lesley; Virgil L Woods
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-08       Impact factor: 11.205

5.  GlobPlot: Exploring protein sequences for globularity and disorder.

Authors:  Rune Linding; Robert B Russell; Victor Neduva; Toby J Gibson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

6.  NORSp: Predictions of long regions without regular secondary structure.

Authors:  Jinfeng Liu; Burkhard Rost
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

7.  Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.

Authors:  Karen A Selz; Arnold J Mandell; Michael F Shlesinger; Vani Arcuragi; Michael J Owens
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

Review 8.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

9.  To be folded or to be unfolded?

Authors:  Sergiy O Garbuzynskiy; Michail Yu Lobanov; Oxana V Galzitskaya
Journal:  Protein Sci       Date:  2004-11       Impact factor: 6.725

10.  NMR screening and crystal quality of bacterially expressed prokaryotic and eukaryotic proteins in a structural genomics pipeline.

Authors:  Rebecca Page; Wolfgang Peti; Ian A Wilson; Raymond C Stevens; Kurt Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.